SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-15-048072
Filing Date
2015-02-13
Accepted
2015-02-13 06:17:35
Documents
2
Group Members
ARNOLD L. ORONSKYGILBERT H. KLIMANHARVEY B. CASHINTERWEST INVESTORS VII, LPINTERWEST MANAGEMENT PARTNERS VII, LLCNINA S. KJELLSONPHILIP T. GIANOSW. STEPHEN HOLMES III

Document Format Files

Seq Description Document Type Size
1 SC 13G d873184dsc13g.htm SC 13G 155783
2 EX-A d873184dex99a.htm EX-99.A 9704
  Complete submission text file 0001193125-15-048072.txt   167131
Mailing Address
Business Address 3000 SAND HILL RD 3-255 MENLO PARK CA 94025 6508548585
INTERWEST PARTNERS VII L P (Filed by) CIK: 0001081736 (see all company filings)

IRS No.: 943319533 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Subject) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88403 | Film No.: 15608891
SIC: 2834 Pharmaceutical Preparations